S
ince commercial total elbow arthroplasty was first introduced by Dee 1 , many studies have shown the successful results of total elbow arthroplasty with improvements in implant design and better understanding of elbow joint biomechanics [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Considering the favorable results of total elbow arthroplasty in patients with rheumatoid arthritis, the indications were expanded to include the management of osteoarthritis and posttraumatic sequelae as well as the initial treatment of comminuted distal humeral fracture in the elderly 2, 5, 6, [15] [16] [17] [18] [19] [20] . Recently, indications were expanded further to include low-demand young patients with elbow arthritis or patients who might be expected to comply with limited use following the elbow arthroplasty [21] [22] [23] . Thus far, to our knowledge, there have been few reports of total elbow arthroplasty in young patients. The possible reason for this lack of published data is the avoidance of total elbow arthroplasty in young patients due to the high rate of early failure related to overuse. Barthel et al. 15 reported that age at time of arthroplasty was associated with an increased risk of complications; therefore, total elbow arthroplasty is best performed in low-demand older patients. However, besides total elbow arthroplasty, very few options provide satisfactory functional ability in young patients with advanced elbow arthritis. When total elbow arthroplasty is performed in young patients, an acceptable implant survival rate may be expected, if such patients are involved in low-demand activities with respect to the use of their elbow.
The purpose of this study was to evaluate clinical and radiographic outcomes of total elbow arthroplasty in young patients. We hypothesized that total elbow arthroplasty in young patients would demonstrate good clinical results in the early postoperative period, but that outcomes would worsen over time with high loosening and reoperation rates. 
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Materials and Methods

T
his study was retrospective in nature, and final approval of informed consent exemption by the institutional review board was obtained.
Patient Selection
A series of total elbow arthroplasties performed between September 1994 and May 2007 by a single senior author (Y.G.R.) at one institution was reviewed retrospectively. Among the patients, one patient with missing follow-up was excluded. Finally, twenty-three elbows in twenty-one patients who were forty years of age or younger at the time of arthroplasty were enrolled in this study. There were ten male patients and eleven female patients. Two female patients underwent bilateral arthroplasty. The mean patient age at the time of the surgical procedure was thirty-three years (range, twenty to forty years), and the mean follow-up duration was 129 months (range, eighty-five to 227 months).
The right elbow was involved in thirteen cases, and the left elbow was involved in ten cases. Six elbows had osseous ankylosis and three elbows had fibrous ankylosis (Table I ).
In the overall series, semiconstrained-design implants were used, and cement fixation was performed in all patients. Coonrad-Morrey prostheses (Zimmer, Warsaw, Indiana) were used in twelve elbows and Pritchard-Walker Mark II prostheses (Depuy, Warsaw, Indiana) were used in eleven elbows. The diagnoses before surgery were posttraumatic arthritis (nine elbows), rheumatoid Mayo Elbow Performance Score* (points)
28.9 ± 6.6 75.0 ± 11. 1784
arthritis (nine elbows), hemophilic arthropathy (four elbows), and secondary osteoarthritis due to infection sequelae (one elbow).
Preoperative and Postoperative Evaluations
Clinical Assessment
We conducted a retrospective analysis of prospectively collected patient data. The senior author (Y.G.R.), an orthopaedic surgeon, examined the patients before and after the surgical procedure. All patients underwent a physical examination one day before the surgical procedure. Postoperative evaluations were performed regularly on an outpatient basis (at one month, three months, six months, nine months, and twelve months postoperatively, and once a year thereafter), and results of the latest follow-up were analyzed. In patients who underwent a reoperation, clinical and radiographic outcomes at the time of reoperation were defined as final outcomes. Preoperative and postoperative subjective pain during active motion was measured with use of a visual analog scale (VAS), with 0 indicating no pain and 10 indicating extremely severe pain. For elbow range of motion, flexion-extension and pronation-supination arcs at 90°of elbow flexion were assessed. The Cassebaum classification 24 was used for range of motion, and the Mayo Elbow Performance Score 25 was used for clinical assessment. At the time of the latest follow-up, patients were asked to evaluate their subjective satisfaction with the treatment on a 100-point scale, with 100 points indicating complete satisfaction.
Radiographic Assessment
Anteroposterior and lateral radiographs were evaluated preoperatively, postoperatively, and at the time of each follow-up visit. The latest follow-up radiographs were examined for radiolucency around the implant. Evidence of radiolucency and loosening at the bone-cement interface was classified as one of the five types described by Morrey et al. 26 . Based on the criteria of Morrey and Adams 25 , the high-grade radiolucency of types III and IV was defined as implant loosening. The criteria for the assessment of wear were previously described by Ramsey et al. 27 . A line is drawn parallel to the yoke of the humeral component, and another line is drawn parallel to the medial or lateral surface of the articular surface of the ulnar component. An angle of intersection of ‡10°b etween these two lines is considered to indicate mild-to-moderate bushing wear.
Statistical Analysis
The Wilcoxon signed-rank test was performed to assess the differences between preoperative data and postoperative data. The Mann-Whitney U test was used to assess differences between posttraumatic and nontraumatic arthritis groups, between elbows with and without preoperative ankylosis, and between CoonradMorrey and Pritchard-Walker Mark II implants. Significance was set at p < 0.05, with associated 95% confidence intervals (95% CIs). Kaplan-Meier survival analysis was used to calculate implant survival rate. The end point for survival was defined as reoperation for any cause. SPSS version 20.0 software (IBM, Armonk, New York) was used for all statistical analyses.
Source of Funding
There was no external funding source for this investigation.
Results
Clinical Outcomes
T he mean subjective VAS score for pain (and standard deviation) during motion decreased from 5.8 ± 1.8 cm (range, (Table II) . According to the Cassebaum classification, results at the time of the latest follow-up evaluation were excellent in six elbows, good in ten elbows, fair in three elbows, and poor in four elbows (Table III) . Among the four elbows with poor outcomes, three elbows belonged to patients with preoperative ankylosis (Cases 4, 10, and 21). The mean Mayo Elbow Performance Score improved from 32.0 ± 9.4 points (range, 10 to 50 points) preoperatively to 81.1 ± 13.7 points (range, 55 to 100 points) at the time of the latest follow-up (p < 0.001). Of the twenty-three elbows, seventeen (74%) had excellent or good outcomes. In the overall series, the mean subjective patients' satisfaction score was 83.5 ± 11.7 points (range, 60 to 100 points) at the time of the latest follow-up.
Comparison of Outcomes Between the Posttraumatic Arthritis Group and the Nontraumatic Arthritis Group
In the posttraumatic arthritis group, from preoperatively to the time of the latest follow-up, the mean flexion-extension arcs improved from 37.8°± 30.3°(range, 0°to 80°) to 120.6°± 11.3°( range, 95°to 130°) and the mean pronation-supination arcs improved from 96.7°± 69.6°(range, 0°to 180°) to 136.7°± 56.5°(range, 45°to 180°) (p < 0.001 for both) (Table II) . In the nontraumatic arthritis group, from preoperatively to the time of the latest follow-up, the mean flexion-extension arcs increased from 24.3°± 27.6°(range, 0°to 70°) to 96.4°± 21.2°(range, 65°t o 135°) and the mean pronation-supination arcs increased from 54.3°± 52.8°(range, 0°to 180°) to 103.2°± 56.6°(range, 0°to 180°) (p < 0.001 for both). Significant differences in extension deficit (p = 0.001) and supination (p = 0.039) were observed between the two groups. In terms of Mayo Elbow Performance Score, there was no significant difference between the two groups (p = 0.159). The mean satisfaction score of the posttraumatic arthritis group was 81.1 ± 12.9 points, whereas that of the nontraumatic arthritis group was 85.0 ± 10.5 points. No significant difference in the satisfaction score was observed between the two groups (p = 0.600).
Outcomes of Elbows with Preoperative Ankylosis
At the time of the latest follow-up, the mean flexion-extension arc of the fourteen elbows without preoperative ankylosis was 116.1°± 16.2°(range, 75°to 135°) ( Table IV) . The mean flexionextension arc of the nine elbows with preoperative ankylosis was 90.0°± 19.0°(range, 65°to 125°). The final improvement of the flexion-extension arc was 90.0°± 19.0°in the ankylosis group and 67.5°± 26.5°in the non-ankylosis group; this difference was significant (p = 0.039). In the ankylosis group, an 
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extension deficit of ‡30°remained in five elbows (Cases 16, 19, 21, 22, and 23) and a major complication requiring an additional surgical procedure developed in one elbow (Case 23). Although patients with preoperative ankylosis showed inferior outcomes in elbow range of motion, the mean patient satisfaction score after total elbow arthroplasty was 90.0 ± 12.0 points, which was significantly higher (p = 0.033) than that of patients without preoperative ankylosis (79.3 ± 11.0 points).
Radiographic Outcomes
At the time of the latest follow-up, twelve (52%) of the twentythree elbows had no radiolucency around either the humeral or ulnar component (Figs. 1-A through 1-D) . A radiolucent line was observed for the humeral component only in six cases, for the ulnar component only in one case, and for both components in four cases. However, of eleven cases in which a radiolucent line was identified, eight showed only a low-grade line of type I or II, without a clinical problem in stability. In three cases (13%), a high-grade radiolucent line of type III or IV was observed, which corresponded to implant loosening (Table V) . The mean angle of intersection between humeral and ulnar component lines as described above was 7.1°( range, 1.0°to 16.6°). Anteroposterior radiographs of four elbows (17%) in full extension showed obvious asymmetry of ‡10°at the yoke. All of these elbows underwent a revision surgical procedure.
Comparison of Clinical Outcomes According to the Implants
A detailed comparison of the postoperative variables in the Coonrad-Morrey group and the Pritchard-Walker Mark II group is presented in Table VI .
Survivorship Analysis
Over the mean follow-up duration of 129 months (range, ninetyone to 181 months), the implant survival period was seven years or more in all cases. Among five elbows that required a reoperation, two underwent a reoperation within ten years and three underwent a reoperation within fifteen years. The estimated implant survival rates according to Kaplan-Meier analysis were 95.2% (95% CI, 85.9% to 100.0%) at eight years and 89.5% (95% CI, 75.3% to 100.0%) at fifteen years.
Complications and Reoperations
Major complications requiring additional surgical procedures developed in five elbows. One elbow was revised for implant failure and four elbows were revised for other reasons. In one elbow (Case 2), humeral implant loosening of type-IV radiolucency and bone loss developed with moderate pain at ninety-one months after primary total elbow arthroplasty, which required revision total elbow arthroplasty and bone-grafting. However, implant loosening of both components recurred after eightyeight months; thus, a second revision total elbow arthroplasty and bone-grafting were performed (Figs. 2-A through 2-D) . 
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After the second revision, the pain improved and the patient's final Mayo Elbow Performance Score was 80 points. In another elbow (Case 7), triceps imbrication was performed for triceps insufficiency at ninety-six months after total elbow arthroplasty. In a patient with rheumatoid arthritis who underwent bilateral total elbow arthroplasty (Cases 11 and 12), postoperative infection with methicillin-resistant Staphylococcus aureus developed at both sides after more than fifteen years; thus, resection arthroplasty was performed on both sides, with a plan for a second-stage reimplantation. In one patient who underwent total elbow arthroplasty for secondary osteoarthritis (Case 23), resection arthroplasty was performed because of infection with methicillin-sensitive Staphylococcus aureus at eighteen years postoperatively.
Discussion
T otal elbow arthroplasty has been shown to reliably resolve pain and to restore function in advanced elbow arthritis 3, 5, 6 . Nevertheless, surgeons tend not to perform arthroplasty because of the high risks of implant loosening and reoperation for young patients with elbow arthritis. Surgical treatments such as arthrodesis and interposition arthroplasty may serve as alternatives, but have been reported to have adverse effects, including high rates of infection, nonunion, and instability [28] [29] [30] . Arthroscopic debridement would not be considered an appropriate surgical treatment option for advanced elbow arthropathy in young patients. As surgeons more frequently encounter younger patients who could benefit from total elbow arthroplasty, the indications for total elbow arthroplasty will continue to expand. However, because of the few reports on implant longevity in younger patients, total elbow arthroplasty is currently used with limitations and caution.
Few reports have focused directly on total elbow arthroplasty in a younger patient population, especially those who were forty years of age or younger. A retrospective study by Celli and Morrey 23 of fifty-five semiconstrained total elbow arthroplasties in patients who were forty years of age or younger (mean, thirtythree years) with posttraumatic arthritis, rheumatoid arthritis, and juvenile rheumatoid arthritis showed a revision rate of 22% with a mean follow-up duration of ninety-one months. Despite the revision rate, fifty-one elbows (93%) had an excellent or good Mayo Elbow Performance Score. Similarly, in the current study, the reoperation rate was 22% for a mean follow-up duration of 129 months, and two patients among them underwent reoperation within ten years. In addition, the superior outcomes in range of motion and function were comparable with those of previous articles on elderly patients 6, 7, 16, 31 . Because patients with elbow arthritis and preoperative ankylosis have severe functional limitations, total elbow arthroplasty is one option for younger patients to obtain a satisfactory functional outcome [32] [33] [34] . Peden and Morrey 34 reported the total elbow arthroplasty results in thirteen patients with elbow ankylosis (mean age, fifty-four years). In their study, total elbow arthroplasty can be reliable in the long term and has a markedly positive impact on patient function and satisfaction, with a mean arc from 37°of extension to 118°of flexion. In the present study, although the final range of motion in the nine patients with elbow ankylosis was not as good as that of patients without elbow ankylosis, patients showed high satisfaction with the surgical results, with favorable outcomes in pain relief and functional improvement. Therefore, total elbow arthroplasty can be an acceptable procedure for selected young patients with elbow ankylosis. However, considering the high risk of complications after total elbow arthroplasty in patients with elbow ankylosis, total elbow arthroplasty should be performed with caution and consideration of the risk-benefit features 32, 34 . A number of reports have indicated various complications after total elbow arthroplasty, such as aseptic loosening, infection, triceps disruption, implant failure, ulnar nerve permanent lesion, and periprosthetic fracture [35] [36] [37] . Little et al. 38 reviewed the existing literature and concluded that incidence rates after total elbow arthroplasty in 3618 cases with a mean age of fifty-eight years were 14% for a radiolucent line and 9% for implant loosening. In the current study, a radiolucent line was found in eleven elbows (48%) at the time of the latest follow-up. However, most cases had low-grade radiolucency without clinical importance; high-grade radiolucency, considered to reflect loosening, was observed in only one elbow in the posttraumatic arthritis group and in two elbows in the nontraumatic arthritis group. The total loosening rate (13%) was similar to the results of previous reports on elderly patients 15, 16, 39, 40 . In addition, obvious asymmetry of ‡10°at the yoke, considered to indicate mild-tomoderate bushing wear, was observed in four elbows (17%) and all of them underwent revision surgery. Bearing wear correlated with the need for revision at least if the angle was >10°.
Celli and Morrey 23 reported that the reoperation rate after total elbow arthroplasty was significantly higher in patients with posttraumatic arthritis than in those with rheumatoid arthritis or juvenile rheumatoid arthritis. In our study, reoperation was performed in two (22%) of the nine patients who underwent total elbow arthroplasty for posttraumatic arthritis. Even with this high reoperation rate in young patients with posttraumatic arthritis, total elbow arthroplasty showed good outcomes in pain relief and functional improvement. Moreover, in the nontraumatic arthritis group, none of the patients had a reoperation within fifteen postoperative years. Our reoperation rate was similar to or lower than that reported after the surgical procedure using some of the alternative therapeutic options, including arthrodesis, interposition arthroplasty, and radiocapitellar replacement 22, [41] [42] [43] [44] . Plaschke et al. 2 reported implant survival rates of 90% at five years and 81% at ten years after the surgical procedure in 324 primary total elbow arthroplasty cases in 234 patients (mean age, sixty-three years) with a mean follow-up duration of 8.7 years (range, zero to twenty-seven years). Our study was performed in young patients with a mean age of thirty-three years, and postoperative survival rates were 95% at eight years and 89% at fifteen years, which were as good as those in elderly patients. Despite this favorable result, we are unable to conclude whether implant longevity in total elbow arthroplasty among young patients is good, because of the small sample size in this study. Additional long-term follow-up study from other centers is necessary to provide an adequate assessment of implant longevity in young patients. Our study had a few limitations. First, being retrospective, it had limitations similar to those of other retrospective studies. However, we conducted a retrospective analysis of prospectively collected patient data on surgical procedures performed by a single surgeon. Second, the number of patients evaluated was relatively small and the patients in this study were generally low demand even though they were younger. However, because of the few studies on total elbow arthroplasty in patients who were forty years of age or younger, the results of this retrospective case series are worth reporting. In addition, two different implants were used in the present study and the choice of implants was not randomized. Generally, Pritchard-Walker Mark II prostheses were used early and Coonrad-Morrey prostheses were used late. However, the bias of using different implants was reduced by assessing results from procedures performed by a single surgeon. We also analyzed the discrimination between the outcomes of the two types of implants used in this study. Lastly, the patients were reviewed at the time of follow-up by the operating surgeon rather than an independent observer. Furthermore, the fact that a single surgeon, an expert in elbow arthroplasty, operated on all of the patients likely affects the generalizability of these data to other surgeons performing this procedure with less frequency.
In conclusion, despite concerns regarding the longevity of total elbow replacements in young patients, long-term followup after total elbow arthroplasty showed significant functional improvement and pain relief. In cases with preoperative ankylosis, a desirable range of motion was difficult to achieve regardless of high patient satisfaction. Total elbow arthroplasty in selected young patients showed acceptable loosening, reoperation, and implant survival rates. n
